HealthStream (NASDAQ:HSTM) Director Sells $40,226.80 in Stock

December 2, 2025 by InsiderTrades.com

Key Points

Director sale: Director Tate Deborah Taylor sold 1,580 shares at an average of $25.46 for $40,226.80, trimming her stake by 6.39% to 23,127 shares (≈$588,813).
$10.0 million buyback and dividend: The board approved a $10.0 million repurchase program (up to ~1.3% of shares) and the company paid a quarterly dividend of $0.031 ($0.12 annualized, ~0.5% yield).
Recent results and street view: HealthStream beat quarterly EPS estimates ($0.20 vs. $0.17) and revenue, trades near its 52-week low with a $753M market cap, and carries a consensus analyst rating of "Hold" with a $28 target.

HealthStream, Inc. (NASDAQ:HSTM - Get Free Report) Director Tate Deborah Taylor sold 1,580 shares of HealthStream stock in a transaction on Wednesday, November 26th. The shares were sold at an average price of $25.46, for a total value of $40,226.80. Following the transaction, the director directly owned 23,127 shares of the company's stock, valued at approximately $588,813.42. The trade was a 6.39% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

HealthStream Stock Performance

Shares of NASDAQ:HSTM opened at $25.39 on Tuesday. The company's fifty day moving average is $26.07 and its 200-day moving average is $27.01. HealthStream, Inc. has a 52 week low of $24.07 and a 52 week high of $34.24. The company has a market capitalization of $753.12 million, a PE ratio of 37.89, a P/E/G ratio of 3.08 and a beta of 0.43.

HealthStream (NASDAQ:HSTM - Get Free Report) last announced its quarterly earnings results on Monday, November 3rd. The technology company reported $0.20 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.17 by $0.03. The firm had revenue of $76.47 million during the quarter, compared to the consensus estimate of $75.52 million. HealthStream had a net margin of 6.89% and a return on equity of 5.70%. HealthStream has set its FY 2025 guidance at EPS. On average, analysts forecast that HealthStream, Inc. will post 0.63 EPS for the current year.

HealthStream announced that its board has approved a share buyback program on Tuesday, November 11th that allows the company to buyback $10.00 million in outstanding shares. This buyback authorization allows the technology company to repurchase up to 1.3% of its stock through open market purchases. Stock buyback programs are generally an indication that the company's board of directors believes its shares are undervalued.

HealthStream Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, November 28th. Stockholders of record on Monday, November 17th were issued a $0.031 dividend. This represents a $0.12 annualized dividend and a dividend yield of 0.5%. The ex-dividend date of this dividend was Monday, November 17th. HealthStream's payout ratio is presently 17.65%.

Analyst Ratings Changes

Several equities analysts have issued reports on HSTM shares. Wall Street Zen downgraded HealthStream from a "buy" rating to a "hold" rating in a research report on Saturday, November 22nd. Canaccord Genuity Group cut their price target on HealthStream from $29.00 to $28.00 and set a "hold" rating for the company in a report on Thursday, August 7th. Finally, Weiss Ratings reiterated a "hold (c)" rating on shares of HealthStream in a research report on Wednesday, October 8th. One investment analyst has rated the stock with a Buy rating and three have assigned a Hold rating to the company's stock. According to data from MarketBeat, the stock presently has an average rating of "Hold" and a consensus target price of $28.00.

Read Our Latest Report on HSTM

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the stock. Copeland Capital Management LLC boosted its position in shares of HealthStream by 15.6% in the 2nd quarter. Copeland Capital Management LLC now owns 882,950 shares of the technology company's stock worth $24,431,000 after purchasing an additional 119,260 shares during the last quarter. Geode Capital Management LLC lifted its stake in HealthStream by 5.3% in the second quarter. Geode Capital Management LLC now owns 766,193 shares of the technology company's stock valued at $21,202,000 after buying an additional 38,868 shares during the period. Acadian Asset Management LLC boosted its holdings in HealthStream by 5.1% during the second quarter. Acadian Asset Management LLC now owns 762,343 shares of the technology company's stock worth $21,077,000 after buying an additional 37,004 shares during the last quarter. JPMorgan Chase & Co. grew its position in shares of HealthStream by 74.6% during the 3rd quarter. JPMorgan Chase & Co. now owns 432,822 shares of the technology company's stock worth $12,223,000 after buying an additional 184,917 shares during the period. Finally, First Eagle Investment Management LLC increased its stake in shares of HealthStream by 0.7% in the 3rd quarter. First Eagle Investment Management LLC now owns 409,398 shares of the technology company's stock valued at $11,561,000 after acquiring an additional 2,900 shares during the last quarter. Institutional investors and hedge funds own 69.58% of the company's stock.

HealthStream Company Profile

(Get Free Report)

HealthStream, Inc provides Software-as-a-Service (SaaS) based applications for healthcare organizations in the United States. The company's solutions help healthcare organizations in meeting their ongoing clinical development, talent management, training, education, assessment, competency management, safety and compliance, and scheduling, as well as provider credentialing, privileging, and enrollment needs.